Symptoms, risk, screening and diagnostic confirmation

Detect Lymphoma is about choosing the right test for the right risk.

A lymphoma guide covering persistent lymph nodes, B symptoms, CBC, LDH, PET-CT, excision biopsy, flow cytometry, Hodgkin and non-Hodgkin lymphoma.

Educational, not personal medical advice. A new, painless, growing lymph node or lump in the neck, axilla/armpit or groin, especially if firm or persistent, should not be watched indefinitely. Drenching night sweats, unexplained fevers, weight loss, itching, chest pressure or abnormal blood counts add concern.
Node

persistent, enlarging or firm nodes need examination.

B symptoms

fever, sweats and weight loss are classic warnings.

Biopsy

excision is often better than a tiny needle sample.

PET-CT

helps stage many lymphomas.

Brief outline

What lymphoma means.

Lymphoma is a group of lymphocyte cancers. Hodgkin lymphoma, aggressive non-Hodgkin lymphoma and indolent lymphoma behave very differently, so tissue diagnosis is crucial.

PET-CT in lymphoma
PET-CT can show metabolically active lymphoma and help stage disease.

Detection frame

Screening is for people without symptoms. Diagnosis is for symptoms, abnormal examination, family history, imaging findings or abnormal labs. The same test can be sensible in one setting and misleading in another.

Do not ignore

Symptoms and signs not to ignore.

Neck, axilla or groin lumpA new enlarging node in the neck, armpit/axilla or groin is the common practical presentation.
Persistent lymph nodeEspecially if firm, enlarging, supraclavicular or unexplained; biopsy is often needed if it keeps growing.
Night sweatsDrenching sweats with fever or weight loss matter.
Chest symptomsMediastinal lymphoma may cause cough, breathlessness or pressure.
Itching or fatigueNon-specific, but important with nodes or abnormal labs.
Abdominal fullnessSplenomegaly or bulky abdominal nodes can present this way.

Risk and genetics

Demographics, risks and genetics.

Age patternHodgkin lymphoma often affects young adults and older adults; NHL increases with age.
Immune suppressionHIV, transplant medicines and some immune diseases raise risk.
EBV and infectionsEBV, HTLV-1, H. pylori and hepatitis C matter for selected subtypes.
Family historyUsually not strongly inherited, but clusters can occur.
Autoimmune diseaseSome autoimmune conditions and treatments raise lymphoma risk.
Prior therapyRadiation or chemotherapy can rarely contribute.

Screening

Who should actually be screened?

There is no routine population screening test for lymphoma. Detection is symptom-led, exam-led, or triggered by imaging or abnormal blood tests.

Triage

CBC, LDH, ESR/CRP

May be abnormal but cannot rule lymphoma in or out.

Imaging

Ultrasound, CT or PET-CT

Maps nodes and helps choose the best biopsy target.

Staging

PET-CT

Important for many FDG-avid lymphomas.

Best tissue

Excision lymph node biopsy

Often preferred for a new growing node because it preserves architecture for Hodgkin vs non-Hodgkin subtype diagnosis.

Add-on

Flow cytometry/IHC/genetics

Defines B/T-cell lineage, markers and rearrangements.

Selected

Bone marrow biopsy

Used in selected staging or cytopenias.

Images, labs and tissue

Useful tests and what they can miss.

Detection usually needs a chain: suspicion, imaging or lab triage, tissue or cytology when needed, then pathology and molecular testing where it changes management.

PET-CT in lymphoma
PET-CT can show metabolically active lymphoma and help stage disease.
PET-CT scanner example
Functional imaging is often part of lymphoma staging.
Full blood count sample
Blood tests can support suspicion but tissue usually decides.

Pros, cons and controversy

Benefits, harms and the false-positive problem.

The trap is repeated antibiotics or reassurance for a persistent enlarging node without a diagnosis. The other trap is over-biopsying tiny reactive nodes without risk features.

Sources and trials

Good starting points.